• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    PerkinElmer (NY: PKI )

    N/A UNCHANGED
    Last Price Updated: 7:00 PM EDT, May 15, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about PerkinElmer

    < Previous 1 2 3 4 5 6 Next >
    PerkinElmer Q4 Sales Inch Up Marginally, Issues Q1 FY22 Guidance Ahead Of Consensus
    PerkinElmer Inc's (NYSE: PKI)  
    Via Benzinga
    Recap: PerkinElmer Q4 Earnings
    PerkinElmer (NYSE:PKI) reported its Q4 earnings results on Tuesday, February 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021
    From PerkinElmer, Inc.
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
    Via Benzinga
    PerkinElmer Earnings Preview
    PerkinElmer (NYSE:PKI) is set to give its latest quarterly earnings report on Tuesday, 2022-02-01. Here's what investors need to know before the announcement. Analysts estimate that PerkinElmer will... 
    Via Benzinga
    Watch for Continued Gains in Shares of PerkinElmer Inc. (PKI)
    Via Investor Brand Network
    Earnings Scheduled For November 2, 2021
    Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •... 
    Via Benzinga
    PerkinElmer Board Declares Quarterly Dividend
    From PerkinElmer, Inc.
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
    Upgrades Canaccord Genuity upgraded the previous rating for Fortuna Silver Mines Inc (NYSE: 
    Via Benzinga
    26 Firms Going Ex-Dividend Next Week, Including CVS Health, APA Corp. And Procter & Gamble
    There are several well known large cap stocks going ex-dividend next week including 4 of our Top 100 Dividend Stocks. 
    Via Talk Markets
    PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 1, 2022
    From PerkinElmer, Inc.
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
    Via Benzinga
    Watch for Continued Gains in Shares of PerkinElmer Inc.
    PerkinElmer Inc. (NYSE: PKI) traded at a new 12-month high today of $199.57. Approximately 157,000 shares have changed hands today, as compared to an average 30-day volume of 1.1... 
    Via Benzinga
    Free COVID Tests: What Stocks Will Benefit?
    The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits. 
    Via Talk Markets
    PerkinElmer to Present Virtually at J.P. Morgan Healthcare Conference
    From PerkinElmer, Inc.
    Via Business Wire
    Composite Rating For ICON Rises To 96; Awaits Breakout
    The IBD SmartSelect Composite Rating ICON stock rose from 94 to 96 Wednesday as the Ireland-based clinical researcher approaches a buy point. 
    Via Investor's Business Daily
    PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Confirms That Omicron Variant Does Not Impact SARS-CoV-2 Detection Capability of its RT-PCR Assays
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer to Present at Evercore ISI HealthCONx Conference 2021
    From PerkinElmer, Inc.
    Via Business Wire
    Here's How Much $100 Invested In PerkinElmer 10 Years Ago Would Be Worth Today
    PerkinElmer (NYSE:PKI) has outperformed the market over the past 10 years by 11.05% on an annualized basis. Buying $100 In PKI: 10 years ago, an investor could have purchased 5.... 
    Via Benzinga
    PerkinElmer Stock, Already Highly Rated, Perks Up Further Amid Brisk Sales, Profit Growth For Its Instruments
    A Relative Strength Rating upgrade for PerkinElmer shows improving technical performance. Will it continue? 
    Via Investor's Business Daily
    Exposures COVID-19
    PerkinElmer, Inc (PKI) Q3 2021 Earnings Call Transcript
    PKI earnings call for the period ending October 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    PerkinElmer to Present at 2021 Stifel Healthcare Conference
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Q3 Earnings, FY21 Guidance Beat Wall Street Expectations
    PerkinElmer Inc's (NYSE: PKI) Q3 revenues increased 21% Y/Y (12% organic) to $1.17 billion, beating the consensus of $1.04 billion. Diagnostics segment posted $654... 
    Via Benzinga
    PerkinElmer: Q3 Earnings Insights
    PerkinElmer (NYSE:PKI) reported its Q3 earnings results on Tuesday, November 2, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
    Via Benzinga
    Recap: PerkinElmer Q3 Earnings
    PerkinElmer (NYSE:PKI) reported its Q3 earnings results on Tuesday, November 2, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
    Via Benzinga
    PerkinElmer Announces Financial Results for the Third Quarter of 2021
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Releases 2021 Corporate Social Responsibility Report
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer Board Declares Quarterly Dividend
    From PerkinElmer, Inc.
    Via Business Wire
    PerkinElmer and Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-Cell Analysis
    From PerkinElmer, Inc. and Honeycomb Biotechnologies, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.